Louise Brooks

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

María C. Marín, Christine A. Jost, Louise Brooks et al. · Nature Genetics · 2000 · 519 citations

Life Sciences, Genetics, Molecular Genetics +16

High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

Tim Crook, John M. Nicholls, Louise Brooks et al. · Oncogene · 2000 · 194 citations

Medicine, Molecular Biology, Oncology +13

p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

Tim Crook, Louise Brooks, Susan Crossland et al. · Oncogene · 1998 · 178 citations

Medicine, Genetics, Oncology +17

Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial

Caitlin Jones, Richard O. Day, Bart W. Koes et al. · The Lancet · 2023 · 158 citations · Full text

Medicine, Anesthesiology, Pharmacotherapy +13

Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions

Paul Smith, Susan Crossland, Gillian A. Parker et al. · Oncogene · 1999 · 107 citations

Medicine, Molecular Genetics, Oncology +15